Latest Asx News

Hastings Technology Metals is on track to commission its Kabin Buri Hydromet Plant in Thailand by June 2026, aiming for first production of premium Mixed Rare Earth Chloride flakes by Q4. The plant promises near-term revenue streams and leverages lower operating costs in Thailand's Eastern Economic Corridor.

Patronus Resources has pledged to back Pan African Resources’ A$311 million acquisition of Emmerson Resources, raising committed shareholder support to about 32%. The backing is conditional on the share exchange ratio, absence of superior proposals, and a positive independent expert opinion.

Racura Oncology has detailed how its lead drug candidate, (E,E)-bisantrene, silences the cancer-driving MYC gene by stabilising G-quadruplex DNA structures, providing critical preclinical validation ahead of ongoing clinical trials.

Multistack International is progressing with the sale of its core assets to Willing Y Limited, maintaining operations cautiously while cash reserves decline amid ongoing operating losses.

Emu NL has secured $1.63 million from its recent rights issue to fund a 10,000-metre drilling program targeting copper anomalies at Yataga Valley, while a $2 million shortfall remains unplaced.

333D Ltd (ASX:T3D) reversed its prior quarter’s cash outflow to report a $71,505 positive operating cash flow for March 2026, driven by growing healthcare digital asset contracts and a strategic Bitcoin holding. The company also deployed $95,800 post-quarter to scale its healthcare-focused platform.

Eureka Group Holdings expands its footprint on Victoria's East Coast by acquiring Frenchview Lifestyle Village and Paynesville Holiday Park, adding nearly 200 sites and increasing its all-age rental portfolio by 17%.

Qube Holdings has obtained an ASX waiver allowing it to deviate from the standard scheme of arrangement timetable, enabling a fully franked special dividend payment and accommodating bidder funding arrangements. The board unanimously recommends shareholder approval, contingent on independent expert support and absence of superior proposals.

Airtasker Limited posted robust 3Q26 results highlighted by strong Australian marketplace momentum and explosive growth in the UK and US. The company reaffirmed its FY26 guidance, underpinned by strategic media partnerships and a solid cash position.

Manhattan Gold Corporation has secured A$3 million to kick off a 4,000m reverse circulation drilling program at its Hook Lake Project in Nunavut, Canada, while expanding its exploration area by 81km² with new mineral claims covering high-grade gold anomalies.

Alterity Therapeutics has unveiled fresh Phase 2 data revealing ATH434’s ability to slow functional decline in Multiple System Atrophy patients, measured by the novel MuSyCA scale. This reinforces the drug’s disease-modifying potential ahead of pivotal Phase 3 trials.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.